```h
PREDILIFE | ALPRE Logo | Annual Report & Investor Relations Data

PREDILIFE | ALPRE - Annual Report & Investor Relations Data

PREDILIFE | ALPRE
Annual Report & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Ticker

ALPRE

Sector

Health Care

Industry

Biotechnology

Country

France

Year Founded

2004

PREDILIFE (ALPRE)

About PREDILIFE

Pioneers of predictive medicine in France, we position ourselves as a player in 6P medicine: Predictive, Preventive, Personalized, Participative, Relevant, Multi-professional.

After 14 years of research and development, Predilife obtained its medical device certification and began marketing predictive assessments: predictive breast cancer assessment, multi-pathology predictive assessments.

At Predilife, we are passionate about serving health, a committed team that works every day to change the rules so that our motto "predict to prevent" is adopted by the greatest number of people.

We accompany companies, healthcare professionals and employees towards the medicine of tomorrow: predictive, personalized and digital. We are working to make predictive medicine accessible to everyone in order to reduce the number of serious diseases.

We believe that predictive medicine will enable effective prevention and thus reduce the risk of serious diseases.

Employees

19

Market Presence

Worldwide

Headquarters

39 RUE CAMILLE DESMOULINS
94800, VILLEJUIF
France

Company Video

Video thumbnail
Click to load video from YouTube

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

PREDILIFE (ALPRE)
Filings & Annual Reports

Filters

View all types
Filing Information Actions

Insider Trading Activity

Person (Position) Type Volume Price Date
None (Other)
Buy EUR 960.00 EUR 4.80 30.07.24
None (Other)
Buy EUR 2,720.00 EUR 6.80 04.07.24
None (Other)
Buy EUR 12,000.00 EUR 6.00 26.06.24
None (Other)
Buy EUR 2,800.00 EUR 5.60 18.06.24
None (Other)
Sell EUR 204,000.00 EUR 24.00 02.05.24
None (Other)
Buy EUR 2,635.60 EUR 4.40 26.04.24
None (Other)
Buy EUR 6,720.00 EUR 4.20 28.02.24
None (Other)
Buy EUR 2,150.00 EUR 4.30 26.02.24
None (Other)
Buy EUR 2,250.00 EUR 4.50 22.02.24
None (Other)
Other EUR 4,800.00 EUR 4.80 20.02.24

PREDILIFE (ALPRE)
Stock & Investor Information

ISINs

Showing 5 of 6
FR0010169920
FR0014002KU7
FR001400ASH6
FR001400DVC5
FR001400I9J7

LEI

9695006IK5NBKHQU9116

Stock Exchange Listings

Euronext Paris

Primary Stock Exchange Listing

View PREDILIFE on main stock exchange

Industry Classification

PREDILIFE (ALPRE)
Related Companies & Peer Group

1NKEMIA Logo

1NKEMIA

IKM

Sector

Health Care

Country

Spain

ISIN

Founded

1NKEMIA specializes in biotechnology research and innovation, offering advanced solutions for the pharmaceutical, chemical, and energy sectors.

2cureX AB Logo

2cureX AB

2CUREX

Sector

Health Care

Country

Sweden

ISIN

SE0010468124

Founded

2cureX AB is a Danish biotech company specializing in functional precision medicine. It develops diagnostic tools to personalize cancer treatment.

4SC AG Logo

4SC AG

VSC

Sector

Health Care

Country

Germany

ISIN

DE000A3E5C40

Founded

1997

4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …

Abera Bioscience AB Logo

Abera Bioscience AB

ABERA

Sector

Health Care

Country

Sweden

ISIN

SE0015245097

Founded

Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed …

ABIONYX Pharma Logo

ABIONYX Pharma

ABNX

Sector

Health Care

Country

France

ISIN

FR0012616852

Founded

ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …

Abliva Logo

Abliva

ABLI

Sector

Health Care

Country

Sweden

ISIN

SE0002575340

Founded

2000

Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …